1. The Nuclear FactorκB Family Member RelB Facilitates Apoptosis of Renal Epithelial Cells Caused by Cisplatin/Tumor Necrosis FactorαSynergy by Suppressing an Epithelial to Mesenchymal Transition–Like Phenotypic Switch
   Giulia Benedetti et al, 2013, Molecular Pharmacology CrossRef
2. ROCK inhibitors for the treatment of ocular diseases
   Ramin Nourinia et al, 2018, British Journal of Ophthalmology CrossRef
3. Remodeling of the Lamina Cribrosa: Mechanisms and Potential Therapeutic Approaches for Glaucoma
   Ryan G. Strickland et al, 2022, International Journal of Molecular Sciences CrossRef
4. Role of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndrome
   Ran Du et al, 2016, Graefe's Archive for Clinical and Experimental Ophthalmology CrossRef
5. Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions
   Rebecca K. Donegan et al, 2016, Journal of Medicinal Chemistry CrossRef
6. Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases
   Muneo Yamaguchi et al, 2017, Journal of Ophthalmology CrossRef